Cargando…

Glycolytic biomarkers predict transformation in patients with follicular lymphoma

Follicular lymphoma (FL) is an indolent neoplasia comprising approximately 20% of lymphomas. FL is generally considered incurable, with a median survival exceeding 10 years. A subset of FL patients experiences histological transformation (HT) to a more aggressive lymphoma, resulting in markedly poor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monrad, Ida, Madsen, Charlotte, Lauridsen, Kristina Lystlund, Honoré, Bent, Plesner, Trine Lindhardt, Hamilton-Dutoit, Stephen, d’Amore, Francesco, Ludvigsen, Maja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244150/ https://www.ncbi.nlm.nih.gov/pubmed/32442224 http://dx.doi.org/10.1371/journal.pone.0233449

Ejemplares similares

High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma
por: Madsen, Charlotte, et al.
Publicado: (2019)

PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation
por: Beck Enemark, Marie, et al.
Publicado: (2021)

Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients
por: Enemark, Marie Beck, et al.
Publicado: (2022)

IDO1 Protein Is Expressed in Diagnostic Biopsies from Both Follicular and Transformed Follicular Patients
por: Enemark, Marie Beck Hairing, et al.
Publicado: (2023)

Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia
por: Holst, Johanne Marie, et al.
Publicado: (2021)

Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma
por: Ludvigsen, M, et al.
Publicado: (2015)

Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling
por: Honoré, Bent, et al.
Publicado: (2022)

Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation
por: Holst, Johanne Marie, et al.
Publicado: (2021)

Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2021)

Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma
por: Bouska, Alyssa, et al.
Publicado: (2016)

Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma – A study from the Danish Lymphoma Registry
por: Andersen, Maja Dam, et al.
Publicado: (2022)

MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma
por: Leivonen, Suvi-Katri, et al.
Publicado: (2017)

Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity
por: Ludvigsen, Maja, et al.
Publicado: (2009)

Atypical burkitt's lymphoma transforming from follicular lymphoma
por: Hwang, Yu Y, et al.
Publicado: (2011)

Proteomic Analysis of Tissue from α1,3-galactosyltransferase Knockout Mice Reveals That a Wide Variety of Proteins and Protein Fragments Change Expression Level
por: Thorlacius-Ussing, Louise, et al.
Publicado: (2013)

Dramatic increase in gene mutational burden after transformation of follicular lymphoma into TdT(+) B-lymphoblastic leukemia/lymphoma
por: Belman, Jonathan P., et al.
Publicado: (2020)

Histologic transformation of follicular lymphoma: pathologists’ viewpoint
por: Maeshima, Akiko Miyagi
Publicado: (2023)

Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients
por: Egeland, Nina Gran, et al.
Publicado: (2020)

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
por: Ludvigsen, Maja, et al.
Publicado: (2023)

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma
por: González-Rincón, Julia, et al.
Publicado: (2019)

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
por: Vajavaara, Heli, et al.
Publicado: (2021)

Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort
por: Holst, Johanne M., et al.
Publicado: (2019)

Serum Proteomic Changes after Randomized Prolonged Erythropoietin Treatment and/or Endurance Training: Detection of Novel Biomarkers
por: Christensen, Britt, et al.
Publicado: (2015)

Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers
por: Ludvigsen, Maja, et al.
Publicado: (2021)

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma
por: Zhong, Mengya, et al.
Publicado: (2021)

Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas
por: Leivonen, Suvi-Katri, et al.
Publicado: (2023)

Characterization of a case of follicular lymphoma transformed into B-lymphoblastic leukemia
por: Ning, Yi, et al.
Publicado: (2013)

A Case Report of the Histologic Transformation of Primary Follicular Lymphoma of the Duodenum
por: Akiyama, Shintaro, et al.
Publicado: (2014)

Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study
por: Kridel, Robert, et al.
Publicado: (2016)

Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin
por: Aune Westergaard Hansen, Gry, et al.
Publicado: (2015)

Correction: Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin
por: Aune Westergaard Hansen, Gry, et al.
Publicado: (2015)

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma
por: Sha, Fushen, et al.
Publicado: (2022)

Transformation Scoring System (TSS): A new assessment index for clinical transformation of follicular lymphoma
por: Shichijo, Takafumi, et al.
Publicado: (2020)

Follicular Lymphoma
por: Yavaşoğlu, İrfan
Publicado: (2015)

Follicular lymphoma
por: Leich, Ellen
Publicado: (2019)

Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer
por: Ludvigsen, Maja, et al.
Publicado: (2020)

PB2124: MYC EXPRESSION ANALYSIS AND PROGNOSIS VALUE IN TRANSFORMED FOLLICULAR LYMPHOMA
por: Liang, J., et al.
Publicado: (2022)

B Cell Lymphoma, Unclassifiable, Transformed from Follicular Lymphoma: A Rare Presentation with Review of the Literature
por: Kanna, Anila, et al.
Publicado: (2015)

Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement
por: Ise, Mikiko, et al.
Publicado: (2018)

A rare case of follicular lymphoma transformed to a high‐grade B‐cell lymphoma in orbit
por: Vaddepally, Raju K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fm81gfd7gobcn4u534v4pk80at